Search

Search bills, members, committees and pages...

Sign In

DAVID KORN

PreviousNext

14 federal lobbying filings, 2023 to 2026.

DAVID KORN is a registered lobbyist named on 14 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 they have filed under, by filings.

RegistrantFilingsReported
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA14—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$19.6M
20254—$37.9M
20244—$31M
20234—$27.1M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
BUDBudget/Appropriations14
CPTCopyright/Patent/Trademark14
HCRHealth Issues14
MMMMedicare/Medicaid14
TRDTrade (domestic/foreign)14

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.Con.Res. 14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…6
H.R. 1262Mikaela Naylon Give Kids a Chance Act6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.R. 2214DRUG Act6
H.R. 890Stopping Pharma’s Ripoffs and Drug Savings For All Act6
H.R. 946ORPHAN Cures Act6
S. 1040Drug Competition Enhancement Act6
S. 1041Affordable Prescriptions for Patients Act6
S. 1095Stop STALLING Act6
S. 1096Preserve Access to Affordable Generics and Biosimilars Act6
S. 1097Interagency Patent Coordination and Improvement Act of 20256
S. 43Skinny Labels, Big Savings Act6
S. 652Protecting Patients from Deceptive Drug Ads Act6
S. 832EPIC Act of 20256
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
H.R. 1574RESTORE Patent Rights Act of 20255
H.R. 3152Patent Eligibility Restoration Act of 20255
H.R. 3160PREVAIL Act5
H.R. 3269ETHIC Act5
H.R. 4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20265
H.Res. 566Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursua…5
S. 1414Expedited Access to Biosimilars Act5
S. 1546Patent Eligibility Restoration Act of 20255
S. 1553PREVAIL Act5
S. 1954Biosimilar Red Tape Elimination Act5

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2026 second_quarter$7.4MJul 20, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2026 first_quarter$12.2MApr 20, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 fourth_quarter$8.4MJan 20, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 third_quarter$9MOct 20, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 second_quarter$7.6MJul 21, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 first_quarter$12.9MApr 21, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2024 fourth_quarter$7.6MJan 21, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2024 third_quarter$6.9MOct 21, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2024 second_quarter$7MJul 22, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2024 first_quarter$9.6MApr 22, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2023 fourth_quarter$6.4MJan 22, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2023 third_quarter$6.4MOct 20, 2023
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2023 second_quarter$6.3MJul 20, 2023
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2023 first_quarter$8MApr 20, 2023